Killian Meara

Truncated ACE2 levels served to discriminate patients infected with SARS-CoV-2 and influenza A.

The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.

PrEP use is estimated to prevent >90% of infections in men who have sex with men and 70% of infections in people who inject drugs.

The MOVe-OUT study will continue to the phase 3 portion and evaluate 800 mg of the therapy administered twice daily.

With vaccine uptake slowing, any information that can help is needed to increase administration.

Genetic changes enable SARS-CoV-2 to enter the body, replicate and trigger out-of-control immune responses.

The biosensor detects fragments of the SARS-CoV-2 virus as well as variants.

Understanding how future waves will impact areas can help officials implement policies to mitigate them.

Those taking methotrexate had lower seroconversion rates compared to controls.

The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.

While infection risk is not eliminated, the vaccine still provided significant protection.

The second wave in South Africa was larger and saw the Beta lineage dominate.

Patients who developed atrial fibrillation had higher levels of two known markers of heart stress.

Interventions after students receive a positive test were ineffective at preventing more infections.

The agency is making the safe return to school in the fall their top priority.

The Sinovac developed vaccine could greatly aid in the global inoculation effort.

Two doses of the Pfizer or AstraZeneca vaccines generated high sero-neutralization against the strain.

While the efficacy of SARS-CoV-2 vaccines have been demonstrated, a lack of data is present for patients with cancer.

Research has shown that some receptors for the virus are linked to male hormones.

Patients receiving both IL-6 and corticosteroids showed lower risks of death and mechanical ventilation.

A single dose of mRNA vaccine proved 81% effective against a SARS-CoV-2 infection.

Testing every 3 days showed a test sensitivity of 98%.

The therapy demonstrated an efficacy of 65.2% against the Delta variant.

The activity was higher than what was recently observed for the South African variant.

94% of the participants in the study developed COVID-19 antibodies.

At the highest dosage, PfSPZ conferred protection for 3 months.

Unvaccinated healthcare workers showed similar levels of antibodies to vaccinated ones.

A discussion about the Association for Professionals in Infection Control and Epidemiology with CEO Devin Jopp.

Screening and isolation protocols were shown to reduce the risk of transmission.

AFHs reported concerns such as staff coming to work sick and lack of PPE.